Cobblestone Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Cobblestone Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$207.01 - $276.09 $287,950 - $384,041	-1,391 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $15,783 - $20,706	70 Added 5.3%	1,391 $404,000
Q3 2019 Nov 08, 2019	BUY	$166.23 - $187.09 $2,659 - $2,993	16 Added 1.23%	1,321 $224,000
Q4 2018 Jan 30, 2019	SELL	$151.91 - $192.21 $3,038 - $3,844	-20 Reduced 1.51%	1,305 $216,000
Q3 2018 Nov 09, 2018	BUY	$167.73 - $192.74 $3,354 - $3,854	20 Added 1.53%	1,325 $0
Q2 2018 Aug 03, 2018	BUY	$145.72 - $169.96 $728 - $849	5 Added 0.38%	1,305 $0
Q1 2018 May 02, 2018	BUY	$151.6 - $177.13 $197,080 - $230,269	1,300 New	1,300 $212,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Cobblestone Capital Advisors LLC , based on Form 13F filings with the SEC.

Stay updated on Cobblestone Capital Advisors LLC with notifications on news.